It combines the EPIMMUN® epidermal immunization via lasermicroporation with the existing transdermal patches technology.
Today the transdermal patches are only available for drugs with small molecules (<500Da). With the P.L.E.A.S.E.® technology the skin is pretreated with lasermicroporation and this makes it possible to deliver big molecules. The EPIMMUN® patch creates a lot of great benefits for the huge vaccine market in a wide range of diseases.
Reproducible compared to microneedles or ID (Mantoux technique)
Painless and needle free